{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Chicago",
      "state": "IL",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "77959",
      "recalling_firm": "Bella Pharmaceuticals, Inc.",
      "address_1": "3101 W Devon Ave",
      "address_2": "N/A",
      "postal_code": "60659-1407",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Telephone",
      "distribution_pattern": "Nationwide within USA",
      "recall_number": "D-1160-2017",
      "product_description": "Bevacizumab Prefilled 30g and 31 gram 1.25mg/0.05mL Syringes, Rx only, Bella Pharma 3101 W. Devon Ave., Chicago, IL 60659, 1 (877) BELLA.",
      "product_quantity": "2,334 syringes",
      "reason_for_recall": "Lack of Assurance of Sterility.",
      "recall_initiation_date": "20170815",
      "center_classification_date": "20170912",
      "termination_date": "20180423",
      "report_date": "20170920",
      "code_info": "Lot #: 3141201, Exp. 9/13/17; 3146966, Exp . 9/20/17; 3160608, Exp. 10/5/17; 3146966, Exp.  11/1/17"
    }
  ]
}